Anxiety News and Research

Latest Anxiety News and Research

TechniScan utilizes NVIDIA Tesla GPUs in WBU system for diagnostic breast imaging

TechniScan, Inc. is featured on NVIDIA's recently posted blog about speeding the amount of time it takes to get breast imaging results into the hands of doctors and patients. NVIDIA is the world leader in visual computing technologies and inventor of the graphics processing unit.

12 Mar 2010

Study explores incidence of eating disorders among type 1 diabetic patients

Diabetics, under the gun to better manage their disease by controlling their food intake and weight, may find themselves in the sticky wicket of needing treatment that makes them hungry, researchers said.

12 Mar 2010

NeuroSearch's MermaiHD study supports potential Huntington's disease modifying properties of Huntexil

NeuroSearch today announced that further analysis of the data from the MermaiHD study with Huntexil(R) (pridopidine) for the treatment of Huntington's disease supports potential disease modifying properties of the drug.

11 Mar 2010

Childhood bad behaviour linked to chronic widespread pain in adult life

Bad behaviour in childhood is associated with long-term, chronic widespread pain in adult life, according to the findings of a study following nearly 20,000 people from birth in 1958 to the present day.

10 Mar 2010

Relaxation therapy as effective as massage therapy

A new randomized trial shows that on average, three months after receiving a series of 10 massage sessions, patients had half the symptoms of anxiety.

10 Mar 2010

National Jewish Health receives $450,000 grant to study how different families adapt to life with food allergies

Families with food-allergic children face a life of constant vigilance and the looming fear of life-threatening allergic reactions. This fear can have a huge impact on an entire family's life, from heightened anxiety to severe limits on their daily activities. Some families cope well with this situation, while others find it extremely stressful and difficult to manage.

10 Mar 2010

Orexigen Therapeutics reports net loss of $15.0M for three months ended December 31, 2009

Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the three months and year ended December 31, 2009.

9 Mar 2010

Novel protein haditoxin in King Cobra's venom discovered

The King Cobra continues to weave its charm with researchers identifying a protein in its venom with the potential for new drug discovery and to advance understanding of disease mechanisms.

9 Mar 2010

Insight into how human brain seeks religion

In the fractious debate on the existence of God and the nature of religion, two distinguished scientists radically alter the discussion. Taking a perspective rooted in evolutionary biology with a focus on brain science, in GOD'S BRAIN (Prometheus Books, $25) renowned anthropologist Lionel Tiger and pioneering neuroscientist Michael McGuire elucidate perennial questions about religion: What is its purpose? How did it arise? What is its source? And why does every known culture have some form of it?

9 Mar 2010

Common psychiatric illnesses: Free online questionnaire helps doctors screen patients

A one-page, 27-item questionnaire that is available free online is a valid and effective tool to help primary care doctors screen patients for four common psychiatric illnesses, a study led by University of North Carolina at Chapel Hill researchers concludes.

9 Mar 2010

Organisational justice causes feelings of embitterment and burn-out at work

New findings suggest the role of organisational justice in causing feelings of embitterment and burn-out at work. Professor Tom Sensky (Imperial College, London, UK) analyzes these data in the current issue of Psychotherapy and Psychosomatics.

9 Mar 2010

Survey challenges long-held assumption: Having health insurance is synonymous with having access to health care

A survey released today by the Center for Healthcare Research & Transformation challenges the long-held assumption that having health insurance is synonymous with having access to health care.

8 Mar 2010

Presentation of results from open-label extension study of Xenazine

Lundbeck Inc. today announced the presentation of results from an open-label extension study of Xenazine- (tetrabenazine) for the treatment of chorea associated with Huntington's disease (HD). Data from this study demonstrated that after an 80-week treatment period, subjects treated with Xenazine experienced a statistically significant reduction in chorea score (p< 0.0001) as measured using the Unified Huntington's Disease Rating Scale (UHDRS) compared with baseline.

6 Mar 2010

RWJF awards $480,000 grant to improve clinical care for low-weight babies

Researchers at UC Irvine and the Charles Drew University of Medicine and Science (CDU) will monitor the day-to-day health of low-birth-weight babies and their parents as part of a comprehensive initiative designed to combat chronic illnesses associated with low-weight births.

5 Mar 2010

Proper treatment can help control psoriasis in most cases

For the approximately 7.5 million Americans affected by psoriasis, the thick, red, scaly, itchy plaques it causes only scratch the surface when it comes to the overall implications of this disease. Now, ongoing research linking psoriasis to other serious medical conditions and the incredible toll it can take on a person's overall quality of life are shifting the way psoriasis is viewed - from a common skin disease to a complex systemic condition.

5 Mar 2010

Researchers develop new model to guide health care financing, resource allocation decisions in the U.S.

A new model that can be used to guide health care financing and resource allocation decisions in the U.S. has been developed by an international group of researchers led by a team from the University of Illinois at Chicago.

5 Mar 2010

Neurocrine Biosciences to sell common stock shares

Neurocrine Biosciences, Inc. today announced that it is offering to sell shares of its common stock in an underwritten public offering. Jefferies & Company, Inc. is the sole book-running manager for this offering. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

5 Mar 2010

'Fake pot' can cause hallucinations and seizures

In the last month, Anthony Scalzo, M.D., professor of toxicology at Saint Louis University, has seen nearly 30 cases involving teenagers who were experiencing hallucinations, severe agitation, elevated heart rate and blood pressure, vomiting and, in some cases, tremors and seizures.

4 Mar 2010

Beneficial Alzheimer's therapies, update on prevention efforts focused at ADI International Conference

Beneficial Alzheimer's therapies that don't use drugs, and an update on prevention efforts, are the focus of the second day's plenary sessions at the 25th International Conference of Alzheimer's Disease International, March 12, 2010 at the Grand Hotel Palace, Thessaloniki, Greece.

4 Mar 2010

Embedded wireless sensors in senior's homes to detect onset of dementia or physical infirmities

Carnegie Mellon University researchers in the Quality of Life Technology Center (QoLTC) will embed wireless sensors in the residences of about 50 older adults who live alone to see if they can detect subtle changes in everyday activities that indicate the onset of dementia or physical infirmities.

4 Mar 2010

Anxiety News and Research

Latest Anxiety News and Research

TechniScan utilizes NVIDIA Tesla GPUs in WBU system for diagnostic breast imaging

Study explores incidence of eating disorders among type 1 diabetic patients

NeuroSearch's MermaiHD study supports potential Huntington's disease modifying properties of Huntexil

Childhood bad behaviour linked to chronic widespread pain in adult life

Relaxation therapy as effective as massage therapy

National Jewish Health receives $450,000 grant to study how different families adapt to life with food allergies

Orexigen Therapeutics reports net loss of $15.0M for three months ended December 31, 2009

Novel protein haditoxin in King Cobra's venom discovered

Insight into how human brain seeks religion

Common psychiatric illnesses: Free online questionnaire helps doctors screen patients

Organisational justice causes feelings of embitterment and burn-out at work

Survey challenges long-held assumption: Having health insurance is synonymous with having access to health care

Presentation of results from open-label extension study of Xenazine

RWJF awards $480,000 grant to improve clinical care for low-weight babies

Proper treatment can help control psoriasis in most cases

Researchers develop new model to guide health care financing, resource allocation decisions in the U.S.

Neurocrine Biosciences to sell common stock shares

'Fake pot' can cause hallucinations and seizures

Beneficial Alzheimer's therapies, update on prevention efforts focused at ADI International Conference

Embedded wireless sensors in senior's homes to detect onset of dementia or physical infirmities

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Anxiety News and Research

Latest Anxiety News and Research

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Newsletters you may be interested in